He was discharged to the hospital for infectious diseases for further consultation and guidance for follow-up. The patient is currently undergoing regular albendazole treatment and is being closely ...

The treatment, tenecteplase (sold as TNKase), delivers a single five-second IV shot, making it a faster, easier option. TNKase was initially approved in 2000 to reduce the risk of death from acute ...